We are live on ! Find out more
CARM

Carisma Therapeutics
CARM

Delisted

CARM was delisted on the 10th of October, 2025.

Back to rankings

93 hedge funds and large institutions have $42.2M invested in Carisma Therapeutics in 2021 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 26 increasing their positions, 29 reducing their positions, and 27 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.07% less ownership

Funds ownership: 1.29% → 1.22% (-0.07%)

5% less capital invested

Capital invested by funds: $44.5M → $42.2M (-$2.3M)

10% less funds holding

Funds holding: 103 → 93 (-10)

10% less repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 29

33% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 27

58% less call options, than puts

Call options by funds: $1.28M | Put options by funds: $3.08M

Holders
93
Holders Change
-10
Holders Change %
-9.71%
% of All Funds
1.43%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
18
Increased
26
Reduced
29
Closed
27
Calls
$1.28M
Puts
$3.08M
Net Calls
-$1.8M
Net Calls Change
-$1.14M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$2.57M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$2.18M
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$1.9M
4
Prudential Financial
Prudential Financial
New Jersey
+$678K
5
Group One Trading
Group One Trading
Illinois
+$449K

Top Sellers

Rank Fund Capital Flow
1
Two Sigma Investments
Two Sigma Investments
New York
-$2.29M
2
Two Sigma Advisers
Two Sigma Advisers
New York
-$1.93M
3
Renaissance Technologies
Renaissance Technologies
New York
-$1.25M
4
Norges Bank
Norges Bank
Norway
-$996K
5
Deutsche Bank
Deutsche Bank
Germany
-$750K
Name Holding Trade Value Shares
Change 		Change in
Stake
IWC
101
Integrated Wealth Concepts
Massachusetts
– -$20K -1,250 Closed
CC
102
Centiva Capital
New York
– -$17K -1,140 Closed
RJFSA
103
Raymond James Financial Services Advisors
Florida
– -$18K -1,133 Closed
Wolverine Trading
104
Wolverine Trading
Illinois
– -$16K -1,058 Closed
HI
105
Harbour Investments
Wisconsin
– -$16K -1,000 Closed
CAN
106
Cetera Advisor Networks
California
– -$12K -740 Closed
QP
107
Quilter Plc
United Kingdom
– -$11K -697 Closed
MAM
108
Meeder Asset Management
Ohio
– -$11K -690 Closed
SSA
109
Schonfeld Strategic Advisors
New York
– -$10K -630 Closed
CA
110
Cetera Advisors
Colorado
– -$9K -550 Closed
TFO
111
Tarbox Family Office
California
– -$3K -200 Closed
SL
112
Savior LLC
Massachusetts
– -$2K -120 Closed
PA
113
Parallel Advisors
California
– -$1K -38 Closed
EI
114
Ellevest Inc
New York
– -$1K -36 Closed
RPCONE
115
Retirement Planning Company of New England
Rhode Island
– +$60 +3 New
ZIG
116
Zullo Investment Group
Pennsylvania
– +$161 +8 New
TWA
117
TCI Wealth Advisors
Arizona
– +$604 +30 New
1 2 3 4
5

CARM Hedge Fund Activity: Q4 2021 in Review

93 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Carisma Therapeutics (CARM) for Q4 2021, worth a combined $42.2M — down 5.2% from $44.5M a quarter earlier.

Sellers outnumbered buyers: 27 funds closed out of CARM and 18 opened new positions — a net loss of 9 holders — while 29 trimmed existing stakes and 26 added.

The largest buyer was BlackRock, adding an estimated $2.57M. The largest seller was Two Sigma Investments, cutting an estimated $2.29M.

  • 93 institutional investors held Carisma Therapeutics (CARM) as of Q4 2021, down from 103 in Q3 2021.
  • Funds reported $42.2M of Carisma Therapeutics stock for Q4 2021, down 5.2% quarter-over-quarter.
  • 18 funds opened new Carisma Therapeutics positions in Q4 2021 and 27 closed out, a net change of -9 holders.
  • The largest Carisma Therapeutics buyer in Q4 2021 was BlackRock, an estimated $2.57M added.
  • The largest Carisma Therapeutics seller in Q4 2021 was Two Sigma Investments, an estimated $2.29M sold.

Based on aggregated 13F filings for Q4 2021.